Zentalis Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Zentalis Pharmaceuticals, Inc.
CIK #0001725160
EDGAR Form CIK 2011 - 2026
10-K [0001725160]
10-Q [0001725160]
3 [0001725160]
4 [0001725160]
8-K [0001725160]
D [0001725160]
SC 13D [0001725160]
SC 13G [0001725160]
Form 13D/13G Filer Form 13D/13G Subject Filed
Squadron Capital Management LLC Zentalis Pharmaceuticals Inc [2026-03-03]
5AM Opportunities II GP LLC Zentalis Pharmaceuticals Inc [2025-12-30]
Barclays PLC Zentalis Pharmaceuticals Inc [2025-11-12]
Millennium Management LLC Zentalis Pharmaceuticals Inc [2025-02-04]
Walters William T Zentalis Pharmaceuticals Inc [2024-12-10]
Citadel Advisors LLC Zentalis Pharmaceuticals Inc [2023-11-17]
Eventide Asset Management LLC Zentalis Pharmaceuticals Inc [2023-10-10]
Tybourne Capital Management HK Ltd Zentalis Pharmaceuticals Inc [2023-02-14]
Capital International Investors Zentalis Pharmaceuticals Inc [2023-02-13]
State Street Corp Zentalis Pharmaceuticals Inc [2023-02-07]
View All
Form 3/4/5 Subject 2011 - 2026
Myers Scott Dunseth
Zentalis Pharmaceuticals, Inc.
Kariuki Enoch
Johnson David Michael
Skvarka Jan
Walker Luke Nathaniel
Campbell Shannon
Vultaggio Vincent
Eastland Julia Marie
Bruns Ingmar
View All
Terms | Privacy | Guide
tony@aum13f.com